HEUKING advises shareholders of Vanguard Automation on sale to stock listed Mycronic AB
June, 2024 - Germany
Please note the following press release. This press release is availableat our homepage.
HEUKING advises shareholders of Vanguard Automation on sale to stock listed Mycronic AB
A team led by Dr. Katharina Prasuhn, partner at the Munich office of HEUKING, advised the shareholders of Vanguard Automation GmbH on the sale of their shares to the Global Technologies Division of Mycronic AB. Vanguard Automation will establish a new business unit within Mycronic AB’s Global Technologies Division.
Vanguard Automation GmbH was founded in 2018 and is headquartered in Karlsruhe, Germany. Vanguard has developed a technology and automated equipment for 3D microfabrication of optical interconnects and offers automated photonics assembly processes and machines for 3D nano-printing in the field of photonic multi-chip integration. Their solutions cover the full range from small-scale prototyping to fully automated mass production.
Mycronic is a Swedish high-tech company engaged in the development, manufacture and marketing of production equipment with high precision and flexibility requirements for the electronics industry. Mycronic’s headquarters are located in Täby, north of Stockholm and the group has subsidiaries in China, France, Germany, Japan, Mexico, the Netherlands, Singapore, South Korea, United Kingdom, United States of America and Vietnam. Mycronic is listed on Nasdaq Stockholm.
Counsel to the shareholders of Vanguard Automation GmbH
HEUKING:
Dr. Katharina Prasuhn (lead; corporate law / M&A),
Dr. Ulrich Jork (corporate law / M&A), both Munich,
Dr. Anton Horn (IP, Media & Technology / Patent Law), Düsseldorf,
Dr. Henrik Lay (tax law), Hamburg,
Dr. Lutz Martin Keppeler (Information Technology & Telecommunications), Cologne,
Dr. Reinhard Siegert (antitrust law),
Dr. Ruth Schneider (antitrust law), both Munich,
Katharina Waszczynski (corporate law / M&A), Hamburg
